Biology Reference
In-Depth Information
Bucci M, Roviezzo F, Posadas I, Yu J, Parente L, Sessa WC, Ignarro LJ, Cirino G (2005)
Endothelial nitric oxide synthase activation is critical for vascular leakage during acute
inflammation in vivo. Proc Natl Acad Sci USA 102:904-908
Cohen AW, Hnasko R, Schubert W, Lisanti MP (2004) Role of caveolae and caveolins in health
and disease. Physiol Rev 84:1341-1379
Creighton J, Zhu B, Alexeyev M, Stevens T (2008) Spectrin-anchored phosphodiesterase 4D4
restricts cAMP from disrupting microtubules and inducing endothelial cell gap formation.
J Cell Sci 121:110-119
Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, Mayadas TN (2005) Regulation
of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap
GTPase. Blood 105:1950-1955
Ding B, Abe J, Wei H, Huang Q, Walsh RA, Molina CA, Zhao A, Sadoshima J, Blaxall BC,
Berk BC, Yan C (2005) Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis:
implication in heart failure. Circulation 111:2469-2476
Draijer R, Atsma DE, van der Laarse A, van Hinsbergh VW (1995a) cGMP and nitric oxide
modulate thrombin-induced endothelial permeability. Regulation via different pathways in
human aortic and umbilical vein endothelial cells. Circ Res 76:199-208
Draijer R, Vaandrager AB, Nolte C, de Jonge HR, Walter U, van Hinsbergh VW (1995b)
Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate,
vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ
Res 77:897-905
Fischmeister R, Castro LR, Abi-Gerges A, Rochais F, Jurevicius J, Leroy J, Vandecasteele G
(2006) Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic
nucleotide phosphodiesterases. Circ Res 99:816-828
Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K,
Mochizuki N (2005) Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell
contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol
Cell Biol 25:136-146
Gloerich M, Bos JL (2010) Epac: defining a new mechanism for cAMP action. Annu Rev
Pharmacol Toxicol 50:355-375
Gupta MP, Ober MD, Patterson C, Al-Hassani M, Natarajan V, Hart CM (2001) Nitric oxide
attenuates H(2)O(2)-induced endothelial barrier dysfunction: mechanisms of protection.
Am J Physiol Lung Cell Mol Physiol 280:L116-L126
Hatakeyama T, Pappas PJ, Hobson RW 2nd, Boric MP, Sessa WC, Duran WN (2006) Endothelial
nitric oxide synthase regulates microvascular hyperpermeability in vivo. J Physiol 574:275-281
He P, Liu B, Curry FE (1997a) Effect of nitric oxide synthase inhibitors on endothelial [Ca2+]i and
microvessel permeability. Am J Physiol 272:H176-H185
He P, Zeng M, Curry FE (1997b) Effect of nitric oxide synthase inhibitors on basal microvessel
permeability and endothelial cell [Ca2+]i. Am J Physiol 273:H747-H755
Hempel A, Noll T, Muhs A, Piper HM (1996) Functional antagonism between cAMP and cGMP
on permeability of coronary endothelial monolayers. Am J Physiol 270:H1264-H1271
Holschermann H, Noll T, Hempel A, Piper HM (1997) Dual role of cGMP in modulation of
macromolecule permeability of aortic endothelial cells. Am J Physiol 272:H91-H98
Houslay MD (2010) Underpinning compartmentalised cAMP signalling through targeted cAMP
breakdown. Trends Biochem Sci 35:91-100
Houslay MD, Baillie GS, Maurice DH (2007) cAMP-Specific phosphodiesterase-4 enzymes in the
cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signal-
ing. Circ Res 100:950-966
Jho D, Mehta D, Ahmmed G, Gao XP, Tiruppathi C, Broman M, Malik AB (2005) Angiopoietin-1
opposes VEGF-induced increase in endothelial permeability by inhibiting TRPC1-dependent
Ca2 influx. Circ Res 96:1282-1290
Keravis T, Komas N, Lugnier C (2000) Cyclic nucleotide hydrolysis in bovine aortic endothelial cells
in culture: differential regulation in cobblestone and spindle phenotypes. J Vasc Res 37:235-249
